Market Reports Center One Stop Market Reaserch Shop MRSA Drugs Market Share, Size, Emerging Trends and Growth, Analysis, Overview and Forecasts 2016-2020 Technavio Announces the Publication of its Research Report – Global MRSA Drugs Market 2016-2020 Technavio recognizes the following companies as the key players in the global MRSA drugs market: Allergan, Merck, Pfizer, and Theravance. Other Prominent Vendors in the market are: Absynth Biologics, AmpliPhi Biosciences, AstraZeneca, Basilea Pharmaceutica , Baxter International, Cellceutix, Cempra, CrystalGenomics, Debiopharm, Galapagos NV, GSK, KYORIN Pharmaceutical, Lytix Biopharma, Melinta Therapeutics, Nabriva Therapeutics, NovaDigm Therapeutics, Paratek Pharmaceuticals, R-Pharm, Savara Pharmaceuticals, Sealife Pharma, Sequella, The Medicines Company, and XBiotech. Browse full report with TOC@ https://marketreportscenter.com/reports/349448/global-mrsa-drugsmarket-2016-2020 Commenting on the report, an analyst from Technavio’ s team said: “Strategic alliances and M&A will be the key trend for market growth. Strategic alliances help co-develop and commercialize drugs. These agreements enable the use of technical expertise from both companies, as well as the use of regulatory and development experience gained by one company for the support of pipeline candidates of another company. They ensure the in-flow of adequate funds from both the companies, reducing liability costs for individual companies in case of failures. M&A are usually intended to increase the market penetration of the acquirer or enhance the product portfolio of the parent company. ” Market Reports Center One Stop Market Reaserch Shop According to the report, growing awareness of diseases will be a key driver for market growth because it has increased the use of drugs. October is celebrated as World MRSA Awareness Month. European Antibiotic Awareness Day was celebrated on November 18, 2014 to raise awareness of antibiotic resistance and promote judicious use of antibiotics. The US Department of Health and Human Services developed Healthy People 2020, which aims to prevent and treat infectious diseases. Other awareness programs include World Hand Hygiene Day on May 5, National Infection Control Week in the third week of October, World Pneumonia Day on November 12, and Antibiotic Awareness Week in the third week in November. These programs help increase the treatment seeking population, thus driving the market. Further, the report states that patent expiries and generic penetration will be the challenges for by the market. The loss of patent exclusivity of branded drugs results in the development of generic formulations, which are similar in quality, dosage form, strength, and efficacy, but less costly. There has been a significant increase in generic competition because of the patent expiries of major MRSA drugs. In the emerging markets of Asia, Africa, and South America, the increase in generic competition is leading to downward pricing pressures, which challenges market expansion. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. Request A Sample copy of This Report @ https://marketreportscenter.com/request-sample/349448 About Methicillin-Resistant Staphylococcus aureus (MRSA) MRSA is an infection of the skin that occurs mostly in hospitals and healthcare facilities. It is treated with commonly-used antibiotics and usually spreads from person to person by direct skin-to-skin contact. Physicians often find MRSA harder to treat than most other strains of Staphylococcus aureus because it is sometimes resistant to commonly-used antibiotics such as methicillin. Technavio’ s analysts forecast the global MRSA drugs market to grow at a CAGR of 1.34% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global MRSA drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic drugs used to treat and prevent MRSA infections. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Market Reports Center One Stop Market Reaserch Shop Technavio's report, Global MRSA Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. To Get Discount On The Report @ https://marketreportscenter.com/request-discount/349448 Connect for more details: Sam Collins Market Reports Center 1-646-883-3044 (US) [email protected]

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.